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Although renal functional changes in thyroid dis-
orders may be clinically self-evident in varied patterns
of water and electrolyte derangement, water retention
or diuresis, the precise sites and character of the renal
cellular effects of the thyroid hormone remain ob-
scure. Indeed, the diversity of responses elicited by
thyroxine (T4), triiodothyronine (T3), and their
variably iodinated analogues in different species, in
different tissues, or even in different portions of the
same cells or subcellular organelles [1—41 makes it
quite difficult at present to formulate reliable heuristic
generalizations. The striking alterations in calori-
genesis, oxygen consumption, growth and develop-
ment, neurohumoral regulation and metabolic activity
of every description cannot yet be correlated with any
single fundamental molecular event. It seems fairly
certain, in fact, that this complexity arises in part from
an interplay of primary, secondary and still more
remote reactions not easily subjected to dissociation
and analysis. This is particularly the case for the
kidney, where changes at the cellular level are modified
and complicated by systemic hemodynamic adjust-
ments that spring from a homeostatic need to assure
excretory balance and that produce in turn still more
striking departures from normal in renal function. The
processes of growth, differentiation and metamorphosis
introduce additional uncertainties because they are
affected by thyroid dysfunction and further modify
response patterns. Study of isolated tissues, cells or
subcellular components may avoid these confusing
difficulties but since it does so at the peril of garnering
data having little relevance to the situation in life,
interpretation must be hesitant and guarded.
Mechanisms of thyroid hormone action in the kidney
The effect of a deficit or an excess of thyroid hor-
mones on the basal metabolic rate in adult animals is
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largely the result of a fall or rise in overall energy
turnover in the kidney, liver, heart and skeletal muscles
with relatively little contribution by other tissues. Just
how this is implicated in temperature regulation and
definable intracellular oxidative activities remains un-
known. Emphasis has been laid by many workers [1—4]
upon the possibility that T4 and Ta may primarily
affect the mitochondria as the principle sites of enzym-
atic oxidation of various substrates with production of
the high-energy bonds of ATP. After administration of
thyroid hormones, a characteristic swelling of the mito-
chondria occurs both in vivo and in vitro in target
organs like the kidney. The cause for this phenomena
remains unknown. The possibility that the swelling
may account for the ability of T4 and its congeners to
uncouple oxidative phosphorylation is particularly
attractive because other uncoupling phenols like di-
nitrophenol (DNP) can also produce the manifesta-
tions of thyrotoxicosis in man and experimental
animals. DNP is ineffective, however, in the treatment
of hypothyroidism, and mild or moderately severe
hyperthyroidism may occur in the absence of either
mitochondrial swelling or uncoupled oxidative phos-
phorylation. Indeed, oxidation and phosphorylation
tend to increase pan passu.
Although mitochondrial dysfunction is undoubtedly
an important feature, whatever its place in the chrono-
logical and causative chain, greater emphasis [5, 6] has
been placed more recently upon the role of the thyroid
hormones in promoting protein synthesis as an
explanation for the rises in enzyme activity, in mito-
chondrial mass and in growth, as well as in oxygen
consumption. This effect and its specificity may well
reside in the character of the interaction between the
hormone and the nucleus. Oppenheimer and his
associates [7] have recently demonstrated limited-
capacity nuclear binding sites which exhibit a high
degree of specificity for L-triiodothyronine. Labeled T3
appeared to be bound to a chromatin nonhistone pro-
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tein in rat kidneys and liver. Similar high-affinity
receptors have been found by Samuels and Tsai [8] in
the nuclei of rat pituitary tumor cells in culture that
respond to physiological concentrations of T3 and T
by enhanced growth. These findings are consistent
with evidence [5, 6] for the view that thyroid hormones
act directly on the nuclei of sensitive cells to regulate
protein synthesis and growth by accelerating nuclear
synthesis (transcription) of new messenger and ribo-
somal RNA. Amino acid incorporation into protein in
cell-free preparations is not influenced by adding T4,
a fact which indicates that translation by the ribosomes
is affected little, if at all [9]. According to Wolff and
Wolff [3], an actual increase in enzyme protein has not
been demonstrated in most instances, however, where
enzyme activity has been enhanced rapidly, and it is
possible that T4 and T3 may also have a direct effect
upon enzyme activation and the supply of substrate or
cofactors.
Whittam [10] has suggested that cation transport
may exert a "pacemaker effect" upon cellular respira-
tion as a result of a coupling of the hydrolysis of ATP
by membrane sodium-potassium activated ATPase
during transport with oxidative phosphorylation of
ADP by the mitochondria. Support for the pace-
maker hypothesis has been adduced from finding a fall
in oxygen consumption by rabbit brain and guinea pig
kidney slices and homogenates exposed to low
concentrations of ouabain or after replacement of
sodium by choline following sodium depletion.
Recently Ismael-Beigi and Edelman [11, 12] have
reported that ouabain (10 M) reduces the increment
produced by T3 therapy in the oxygen consumption of
slices of rat kidney, liver and diaphragm by 46 to 90%.
They interpret this response as evidence of a direct
stimulation of Na-K-ATPase by T3 and argue that it
may be operative also in the intact organ in situ because
the intracellular concentration of sodium falls and
potassium rises significantly in diaphragm and heart
of hypothyroid rats treated with T3. It should be
noted, however, that Smith and Samuel [13] have
observed a rise rather than a fall in erythrocyte sodium
during hyperthyroidism in man, in association with a
significantly lower sodium efflux than normal. More-
over, Matty and Green [14] found that T3 and T4 can
increase oxygen uptake by the isolated toad bladder by
l00% both in sodium-containing and sodium-free
media, and concluded that thyroid hormone is not
"directed specifically to sodium kinetics." In the
intact rat, Katz and Lindheimer [15] have brought
forward evidence that changes in renal tubular
Na-K-ATPase activity produced by thyroidectomy
(fall) or T3 administration (rise) are adaptively corre-
lated with changes in loads of sodium imposed upon
the tubules for reabsorption independently of the
thyroid state. Thus, when hypothyroid rats were uni-
nephrectomized or treated with methylprednisolone,
sodium reabsorption rose markedly to the euthyroid
level, together with a rise in Na-K-ATPase activity
despite persistent hypothyroidism. They did not
determine the effect of ouabain, and failed to deter-
mine the effect of these procedures on sodium reabsorp-
tion in the euthyroid kidney as a basis for comparison.
It is entirely possible that thyroid hormone-dependent
augmentation in thermogenesis and in oxygen con-
sumption is, as Ismael-Biegi and Edelman claim,
ouabain-sensitive and coupled in some manner with
energy metabolism, possibly through the ATP-to-
ADP-to-ATP cycle, but it must be stressed that the
stoichiometric relation between cation transport and
oxygen utilization differs widely in the kidney slice
(about 4 Eq/mole 02), with multidirectional transport
into and out of cells, from that which obtains in the
kidney in situ (24 Eq/mole 02) where unidirectional
transport is involved [10].
Among the considerations that must be evaluated in
determining the mechanisms by which thyroid hor-
mones affect renal function is to be included the up-
take and metabolism of hormones by the kidney.
Although T4 and T3 are both tightly bound by albumin
and by the specific thyroxin-binding globulin in the
plasma, binding sites in the cell membrane, in organ-
elles and in cytosol of sensitive cells evince at least an
equally great affinity that assures uptake in most
tissues. In view of the prominence of the renal and
hepatic circulations in accommodating more than 50%
of the cardiac output per minute at rest, it is not sur-
prising that labeled T3 and T4 have been found to be
concentrated most rapidly by kidney and liver [16].
Turnover is very rapid in the kidney because of
deamination, deiodination and excretion as iodide.
Although renal deiodination is enhanced in hyper-
thyroidism and depressed in hypothyroidism, there is
little evidence [16] that it plays a role either in pro-
ducing change in the kidney or in the overall metabolic
state—as, for example, by producing a more active
metabolite.
The search for a single clear-cut modus operandi for
thyroid hormones from which all the diverse and
variegated manifestations derive has not yet been
successful and may never be. Nevertheless, the varied
tissue responsivity might well conceal a relatively
simple basic mechanism that gives rise to a proliferat-
ing and variously convoluted train of consequences.
This is peculiarly true for the kidney, where an orderly
differentiation of parts is essential to function at every
age, where coordinated extrarenal influences are major
physiologic determinants and where dependence
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upon a complex structural-functional organization
casts doubt upon the validity of simplistic conclusions
drawn from studies of other less heterogeneous tissues
such as the liver or heart. Obviously, much work needs
to be done in simply extending information now readily
obtainable by the techniques at hand. The intrarenal
loci of thyroid hormone metabolism, the character and
nephron localization of T3 and/or T4 binding sites in
nuclei and cytosol and the sequence of responses in
different parts of the nephron and the kidney as a
whole are among the many aspects that all require
definition. The pattern of shifts consequent upon and
perhaps responsible for growth and progressive
differentiation during life are particularly in need of
elucidation.
Renal growth and development
The striking importance of the thyroid hormones in
the regulation of amphibian metamorphosis, first
observed by Gudernatch in 1912, is evident not only in
the premature maturation induced by Ta and T and in
arrest in the larval stage after thyroidectomy but also
in abnormalities in total body size. Differentiation and
maturation appear to be regulated (at least in part) by
the thyroid in most vertebrate species. Little is known
about its effect upon renal differentiation. Overall
renal growth is much more markedly affected than total
body growth in young rats. Thus, in our own un-
published studies confirming much earlier work [17,
18], body wt in male rats was found to increase by only
26%, on the average, over a period of eight weeks after
intraperitoneal injection of 1 mCi of ''I, in contrast
to an average increment of 97% in untreated litter
mates. Renal growth, on the other hand, was much
more markedly affected,falling on the average by 10%
instead of rising by 59% as it did in the normal litter-
mates over the same period. Administration of T3
(50 tg/100 g of body wt at 48 hr intervals) retarded or
arrested body growth within one week (233 SE 3 g in
comparison with 253 4 g in weight-matched controls,
in a study by Katz and Lindheimer [15]), while renal
growth continued or accelerated significantly (1.84
0.05 g, compared with 1.49±0.03 g in the controls).
It is interesting that body growth is much more
markedly accelerated by thyroid hormones in the
hypothyroid animal. This "catch-up" growth may be
presumed to entail the usual orderly differentiation of
organ systems, but it often fails to compensate com-
pletely for the deficit. The character of the response of
the kidney in this situation has not been explored, nor
is it known if a relative renal functional impairment or
imbalance may be involved. A somewhat different
type of compensatory hypertrophy that follows unine-
phrectomy is enhanced by administration of thyroid
hormones and diminished but not prevented by hypo-
thyroidism (19). In a study by Réville and Stephan
(unpublished data), summarized in Fig. 1, kidney wt
increased significantly in adult female hypothyroid
(''I treatment) rats 21 days after unilateral nephrec-
tomy (open circles—control; closed circles—hyper-
trophic kidney wt), without change in the highly signifi-
cant (P<0.001) correlation (control: r=0.882; hyper-
trophy: r =0.884) between body wt and kidney wt. In
age-matched euthyroid control rats, the weight of the
residual kidney (open triangles) 21 days after unilateral
nephrectomy had increased on the average above the
control kidney wt (crosses) much more, in both per-
centile (24% as compared with 15% in the hypo-
thyroid animals) and absolute terms (0.22 vs. 0.07 g),
without loss of the highly significant correlation be-
tween kidney and body wt (r=0.769 in euthyroid con-
trols; r =0.608 with hypertrophy). To what extent the
nephron population is uniformly implicated in these
changes remains unknown. Although the renal
atrophy of hypothyroidism is not produced by loss of
nephrons, it is possible that compensatory hyper-
trophy [20] or increased growth with an excess of
thyroid hormone may entail the addition of newly
formed units, at least in very young animals, if not in
adults [21]. In any case, the increment in growth
entails cell division and not simply cellular enlarge-
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Fig. 1. Effect of uninephrectomy on renal weight in ezithyroid and
hypothyroid rats. Interrupted (control kidney) and solid (hyper-
trophic kidney) regression lines calculated by the least squares
method.
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ment. The mean doubling time of human kidney epi-
thelial cells in tissue culture is reduced by 25% after
exposure to T4 [22], and in vivo T4-induced hyper-
trophy is associated with a rise in mitotic index [23]. It
is not known, however, if the different parts of the
nephron respond uniformly to the hormonal or hyper-
trophic stimulus. In euthyroid animals the additional
growth of compensatory hypertrophy is definitely
more marked in the proximal convoluted tubules than
in the glomeruli [24, 25], but in hypothyroidism
glomerulotubular dimensions are already disparately
affected in the opposite direction [26] and hypertrophy
in this situation might actually produce a seemingly
"corrective" change.
Measurements of nephrons microdissected from the
kidney of hypothyroid ('311-treated) rats have shown a
significant departure from the values obtained in
normal rats of the same size [26]. Glomerular surface
area (GS) may be estimated as for a sphere, using an
average of the longest and shortest diameter measured
by eyepiece micrometer and the length of the attached
proximal convoluted tubule (PL) measured by curvi-
meter on a camera lucid drawing. In Fig. 2 the average
glomerular surface is plotted against the average
proximal tubular length for each of 20 hypothyroid
male rats (solid dots) and compared with similar
measurements in 26 normal controls (open circles) of
approximately the same size (275 14.8 g, hypothyroid;
278 16.1 g, normal). In the normal animals, GS and
PL were significantly correlated (r =0.9297, P <0.001),
and the values clustered closely around the regression
line. The values for GS in the hypothyroid rats did not
differ from normal (55.2±2.Ox l0- mm2, hypo-
thyroid; 53.7±2.5x 10 mm2, normal), whereas PL
was significantly shorter (7.6 0.4 mm as compared
with 9.6 0.3 mm). As a consequence all the values for
the hypothyroid rats fell to the left of the normal
regression line and showed much more scatter,
though GS and PL were still significantly correlated
(r=0.5855, P<0.005). The shift in dimensional
glomerulotubular balance evident in these figures for
the total nephron population was clearly demonstrable
also for nephrons considered individually.
The data presented in Fig. 3 were drawn from a
study of two littermates, one of which had been treated
with radioiodine. Measurements of glomerular sur-
face areas plotted against the lengths of attached
proximal convoluted tubules of 28 nephrons selected
in approximately equal numbers from superficial,
intermediate and juxtamedullary cortex of the euthy-
roid control (open circles—Fig. 3) fell closely around
the regression line obtained for the control series of
animals in Fig. 2. All but one of the measurements of
nephrons dissected in the same manner from the
kidney of the hypothyroid littermate (solid dots) fell
to the left of the regression line. Since the animals were
age-matched, and not weight-matched (body wt:
mm2 x 1O
Fig. 2. Dimensional glomerulotubular relationships in normal and
hypothyroid rats. The normal regression equation and correla-
tion coefficient are shown. Reprinted from [27] with permission.
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Fig. 3. Effect of hypothyroidism on glomerular and proximal
tubular dimensions. Euthyroid littermates were used as controls.
Note that all but one of the data from hypothyroid rats fall to
the left of the normal regression line. Reprinted from [27] with
permission.
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euthyroid, 442 g; hypothyroid, 263 g), both GS and PL
were lower than in the control. The length of the distal
convoluted tubule appears to be smaller than normal,
roughly in proportion to the proximal convolution
[26]. These findings indicate that glomerular growth is
retarded in the hypothyroid rat to the same extent
that total body growth is. The remainder of the
nephron, however, suffers a more marked interference,
and the kidney becomes progressively more atrophic
with respect to total body mass. Whether a glomerulo-
tubular dissociation also occurs during the accelerated
growth induced by hormone excess has not yet been
determined.
No clear-cut histologic evidence of an imbalanced
growth effect has been reported. Glomeruli and tubules
show relatively little abnormality in the hypothyroid
rat. Accumulations of a glycoprotein material appear
in the cisternae of the endoplasmic reticulum of the
podocytes in the absence of change elsewhere in the
cell. Tubular atrophy appears to be associated with an
irregular thickening of the basement membrane and
occasional infiltration of basal material into the inter-
cellular spaces [28].
According to Evan et al [29], the cells of the atrophic
short proximal convolutions in hypophysectomized
rats are smaller than normal (weight-matched con-
trols) and show by electron microscopy an increase in
size and number of dense bodies, decreased smooth
endoplasmic reticulum and decreased basilar infold-
ings. Other workers [30, 31] have observed thickening
of the glomerular and tubular basement membranes in
biopsy specimens from patients with hypothyroidism.
To what extent malnutrition may play a role in produc-
ing these changes, to what extentdissociation of vascular
and parenchymal growth may be ascribed to differing
neurohumoral influences other than the thyroid, and
to what extent extrarenal circulatory and fluid distribu-
tional readjustment may be implicated remain un-
known. Finally, it must be emphasized that data of
this kind, obtained in the growing rat, may not be
applicable or transferable to adulthood—in man or
any other mammalian species—when growth has
ceased. It would be of great interest to know if the
same changes do indeed occur in the young of other
species.
Renal circulation and glomerular filtration
Among the most impressive manifestations of an
excess or a deficit of thyroid hormones are those pro-
duced by cardiovascular overactivity or depression. In
hyperthyroidism, a hyperdynamic circulation charac-
terized by an elevation in cardiac output, tachycardia,
diminished peripheral vascular resistance and a
tendency to a rise in arterial pressure appears to be
associated with an increase in renal blood flow.
Measurement of p-aminohippurate (PAH) clearance
in a total of 27 hyperthyroid patients has been found
[32] to yield results well above normal in almost every
instance. Since renal extraction of PAH has been
reported [33] to be normal, and since many factors not
mentioned in these studies, such as cardiac incom-
petence, emotional instability and varied medications,
might well have predisposed to a vasoconstrictive
response, the conclusion that intrarenal vasodilatation
occurs seems well-founded. Cutler, Glatte and
Dowling [34], however, have failed to find any change
in PAH clearance from normal in nine patients with
well-documented hyperthyroidism before or after
successful therapy. Their studies were made after 36
hr of dehydration with collection of urine by volun-
tary voiding in the upright position so that a secondary
vasoconstriction may well have been induced. Un-
fortunately, the data available are too scattered,
fragmentary and incomplete to permit a confident
judgment. A systematic evaluation of the renal
circulatory response to excessive thyroid hormone in
man must entail determination of PAH clearance
under carefully controlled and reproducible conditions,
combined with measurements of PAH extraction,
simultaneous cardiocirculatory parameters and circu-
lating vasoactive agents that may be important
determinants, such as the renin-angiotensin system,
catecholamines and prostaglandins. The array of
evidence [35] indicating that many of the features of
altered thyroid function may be mediated through
changes in peripheral adrenergic activity strongly
suggests that renal vasomotor reactivity may be simi-
larly modified. In animals, the techniques currently
available for direct measurement of renal blood flow
and vascular pressures in the conscious normally
active state and for exploration of intrarenal distribu-
tion of perfusate could furnish much needed and
illuminating data. All these considerations apply with
equal or greater force to hypothyroidism, where even
less is known with certainty about renal hemodynamics.
In a combined series of 14 women and 11 men with
uncomplicated hypothyroidism drawn from the
literature [33, 36—39], effective renal plasma flow
(ERPF) measured as the Diodrast or PAH clearances
averaged 442±35 mI/mm, approximately half the
average normal despite maintenance of arterial pres-
sure. The intrarenal vasoconstriction indicated in this
value is roughly proportional to that elsewhere in the
body, since in four subjects cardiac output (direct
Fick) has been found [37] to fall to the same extent
with maintenance of renal fraction within normal
limits. Just how and why the vasoconstriction should
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occur is by no means clear. The extraction of PAH has ferrocyanide has been employed because it may be
been found to be reduced to 78 and 66% in two precipitated in situ as insoluble and easily visible
patients; so the clearance values are open to some crystals of Prussian Blue that are not lost during
suspicion [33]. It is also legitimate to wonder if the subsequent acid maceration, microdissection and
circumstances in which measurements were made could separation of nephrons for study [48, 49]. Measure-
have played a role, or if various complicating condi- ment of the nephron dimensions, the distance filtrate
tions such as anemia, heart failure, medications, were containing ferrocyanide has moved down the tubule
involved, during the time interval between injection and ligation
Renal hypoperfusion has been reported [40—42] in of the renal pedicle, and the nephron content of radio-
experimental animals also, though the tendency to a activity make possible computation of SNGFR and
persistent reduction in arterial pressure, to a marked filtrate velocity in each unit. In the hypothyroid rat,
depressive and hypotensive response to anesthetic SNGFR has been found to be reduced uniformly in
agents, and to salt and water depletion under these all parts of the kidney without any evidence of re-
circumstances causes some insecurity in interpreta- distribution of filtrate (and presumably perfusate).
tion. In the rat, at any rate, it would seem reasonable The close correlation of SNGFR and GS observed
to suppose that the structural change might favor an normally is maintained (r = 0.6286, P <0.001 in the
increase in perfusion relative to kidney weight, but the hypothyroid; r=0.5952, P<0.005 in the euthyroid
data available on hemodynamics are insufficient to littermate control—Fig. 4). (Values for GS and PL of
make it possible to reach any conclusion. Studies of nephrons from the kidneys of these animals are
changes in glomerular filtration rate (GFR) are more presented in Fig. 3.) The hatched areas indicating the
numerous and helpful, not only in providing an index expected normal limits for SNGFR for rats of their
to circulatory change but also as a basis for evaluation body wt (namely, 442 and 263 g, respectively) were
of tubular function which depends initially upon the constructed from the regression equation defining the
character and quantity of filtrate loading. In both
hyper- and hypothyroidism, GFR has usually been
found to change in the same direction as perfusion,
rising above normal in the former and falling in the
latter. The inulin clearance was found to average
145.5 5.6 ml/min in 36 hyperthyroid patients reported
,//m/n
ioo
.
90
by seven groups of workers (32, 33, 36, 38, 40—46),
significantly higher (P <0.001) than the normal value,
116.5 4.0 mI/mm, of Smith [47]. The value fell in 12
80
of 14 patients who were studied again after successful
therapy. In contrast, Cutler and his associates [34]
have reported figures that were lower than normal
(averaging 102.9 3.8 ml/min) in nine hyperthyroid .
patients and that failed to change significantly with
therapy, in agreement with their findings noted above 50
for ERPF. There seems to be little doubt that hypo-
thyroidism is nearly always associated with a marked
reduction in GFR in man and experimental animals,
•
falling to 71 mI/mm on the average in 17 patients
and rising toward normal in six of seven followed after 30 •
correction. In both groups the filtration fraction did
not differ greatly from normal (averaging 17.2 0.9% 20 •
for the hyperthyroid patients and 17.4 I .0% for the
.
hypothyroids) and showed no consistent change with
therapy.
I I
80 90
Although vascular, intraglomerular and intra-
tubular pressures have not yet been evaluated in
kidneys affected by an excess or deficit of thyroid Fig. 4. Correlation between glomerular surface area and SNGFRin a hypothyroid rat and its euthyroid littermate. Hatched
hormones measurements of the filtration rates in
.individual glomeruli (SNGFR) have been made under
these conditions. For this purpose, '4C-labeled sodium
rectangles depict mean SEM of the expected values for rats of
identical body weight, taken from a larger series of rats. Hypo-
thyroid values are well below the expected normal. Reprinted
from [27] with permission.
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relationship between body weights in a larger series of
normal rats and their average SNGFR and GS (un-
published data). The values for the normal littermate
(GC—open circles) fell within or about the relevant
cross-hatched area, whereas those for the hypothyroid
littermate GH fell well below and outside the second
lower cross-hatched area applicable to a normal rat of
the same weight, 263 g. Glomerular surface areas in
OH fell closely about the expected mean averaging
49.4±1.6x lO- vs. 51.0±5.2xlO3 mm2 expected.
The value for SNGFR (23.0 0.73 nI/mm) was 36.7%
of the euthyroid control (62.7 2.8 nI/mm) and 61.9%
of that expected (37.1 6.2 ni/mm) for a normal rat of
the same weight. It is noteworthy that glomerular
filtration rate (3H-inulin clearance) for the kidney as a
whole in GH was 39.7% of that for GC, in close
agreement with the difference observed in SNGFR.
These data demonstrate for individual nephrons and
for the nephron population as a whole that glomerular
filtration was diminished in the hypothyroid rat
despite maintenance of a normal filtering surface area.
It may be concluded that filtration is geared to the
reduced capacity of the tubule receiving it. Similar
data are not yet available for hyperthyroidism in rats
but preliminary study indicates that the nephron
population participates uniformly without redistribu-
tion in the rise in filtration. Once again it must be
emphasized that any generalization from these findings
is to be taken cum grano salis since the data apply with
certainty only to the situation in which they were
obtained, i.e., in the anesthetized animal after abdomi-
nal surgery. Of special concern is the difficulty of
normalizing the results in suitable physiologic terms.
Should SNGFR, for example, be referred to body
weight, to kidney weight, to GS, to PL or to some
other standard? This problem becomes worrisome in
evaluating water and electrolyte excretion where addi-
tional unknowns enter the equation. On the one hand,
alterations in metabolic balance with altered intake of
fluid and food and with change in production of urea
and other end-products serve to place abnormal loads
upon the kidney. And on the other, augmented or
diminished urine formation may so distort body water
and solute concentrations and distribution as to
induce new metabolic derangements.
Tubular functions
The reference base. In any quantitative appraisal of
urine formation and the discrete renal tubular pro-
cesses involved in processing glomerular filtrate by
active (and passive) bidirectional transfers of water
and solute, it is necessary not only to allow for
extrarenal influences but also to employ an appro-
priately weighted standard of comparison. On first
thought, the body wt and, better yet, kidney wt, would
appear to be the most suitable factors by which data
could be normalized. In dog, cat, rat and other
experimental animals where body size may range quite
widely, either factor may prove helpful in reducing the
spread of apparent variation among individuals. As
noted above, however, thyroid disorders appear to
affect body and kidney size disproportionately, and it
seems much safer to depend upon renal weight alone
as a measure of the active cell mass. Even here, how-
ever, intrarenal disproportionalities must introduce
uncertainty, since serious dysfunction may well arise
as a result of glomerulotubular or intersegmental
imbalances in loading without a fundamental abnor-
mality of any kind in cell function. In addition, it is
not certain whether the smaller kidney of hypo-
thyroidism is truly the result of atrophy (and all that
may be entailed in that term) or simply arrested
growth with tubular cells continuing to operate
normally for a kidney of fixed size within a body that
continues to grow and to impose gradually changing
and increasing loads of all kinds. In man and the
intact animal, use of kidney wt as a reference base is
obviously impossible, and other approaches must be
explored.
Theoretically it is conceivable that some functional
equivalent might be found that would be much more
precisely and meaningfully correlated with "active
cell mass" than the weight of the kidney that must
include supportive and conductive elements not
strictly involved in forming urine. For this purpose,
values of maximal tubular reabsorptive (glucose) and
secretory (Diodrast or PAH) activity (Tm) might be
helpful, but a systematic study of the effects of a lack
or an excess of T3 and T4 has not been made. In
scattered studies [32], it has been found that Diodrast
and PAH Tm were greatly reduced in patients with
various forms of hypothyroidism, rising strikingly and
more promptly toward normal on therapy than does
filtration and renal plasma flow. In the dog, also,
Diodrast Tm has been observed to fall quickly to 65 to
75% of control after thyroidectomy and to rise on
treatment with T4 [411. The uptake of PAH by kidney
slices from weanling rat is also stimulated by prior
administration of T3 in sufficient dosage, whereas up-
take is inhibited when T3 is only added in vitro. The
effect seems to be specific for organic acid transport,
since the uptake of N-methylnicotinamide is un-
affected [50]. In the intact animal and in man, PAH
and Diodrast Tm rise within days after beginning a
course of T4 and elevated values of both have been
reported in hyperthyroid patients [32]. Similarly
glucose Tm is increased by excess thyroid hormone and
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diminished in its absence in man and experimental
animals. To what extent these changes are correlated
with renal weight remains unknown.
Preliminary studies in pairs of littermate rats (con-
trol and radioiodine treated) indicate that glucose Tm
and kidney weight decrease to approximately the same
extent in hypothyroidism. Of particular interest was
the further finding that the glucose threshold (deter-
mined by glucose titration) [47] was higher (16 to 5O%)
in the hypothyroid rats than in the euthyroid litter-
mate controls, suggesting that a decline in SNGFR
lowered the filtered glucose "load" more than the
associated defect in tubular function depressed the
capacity to reabsorb glucose. The fact that the plasma
level at which glycosuria was first detectable coincided
closely with that at which saturation of the transfer
system was achieved (absence of "splay") may be
construed as evidence of uniform and more or less
equal involvement of all nephrons. These data not
only give support to the possibility that maximal
transfer rates may be a useful "equivalent" of "active
cell mass" that can be used to evaluate the progress of
structural change without recourse to nephrectomy
and microdissection, but they also throw light upon
glomerulotubular interaction in this disorder. Evi-
dently the intrarenal vasoconstriction responsible for
the diminution in SNGFR under these circumstances
actually overcompensates for the apparent glomerular
dominance evident in the dimensional imbalance. The
pattern and tempo with which these changes occur
must be followed in the rat and other experimental
animals in relation to quantitative evaluation of
structural dimensions to determine if species differences
may not reflect differences as much in the character of
anatomical rearrangement and size as in the intimate
mechanisms of limited transport systems. It is particu-
larly to be hoped that an approach of this kind will
clarify the enigmas of thyroid hormone action upon
salt and water output. The lack of a reliable reference
base upon which to judge the role of the parts and the
whole of the nephron population—its dimensions,
organization and loading by filtrate and tubular
perfusate segment by segment—remains a formidable
obstacle to understanding in this as well as other areas
of renal pathophysiology.
Water excretion and osmoregulation. Interpretation
of defects in water balance and water excretion is
clouded both because the appropriate reference base is
uncertain and because the turnover, body content and
distribution of water are affected not only in disorders
of thyroid function but also in associated disturbances
of other systems. In hyperthyroidism the cardio-
circulatory hyperactivity, the elevated body heat
production with a resultant increase in food and fluid
intake, and abnormalities in gastrointestinal function
all combine to cause erratic and often puzzling changes
in water excretion that cannot be ascribed to primary
renal malfunction. At the other extreme, the curious
and poorly understood phenomenon of "myxedema,"
seldom, if ever, encountered in any animal other than
man, suggests that the factors determining intra-
cellular compartmental volumes may be deranged in
some unknown manner that may well be reflected in
altered intake and output. An increase in extracellular
fluid volume, the inexplicable appearance of isolated
serous effusions and the insidious development of
heart failure fit in with this notion but fail to provide a
substantive basis for quantitative definition of, and
allowance for, extrarenal determinants. Also confusing
this picture and making it still more difficult to mark
out strictly renal mechanisms is the tendency for an
excess of T3 and T4 to stimulate, and for a deficit to
depress, the activity of other endocrine glands (adrenals,
parathyroids) that may affect water movements in one
way or another.
Thyroxine administration (or coincidental hyper-
thyroidism), clearly augments the diuresis of diabetes
insipidus and induces a striking water output in
patients with myxedema and in some with nephrotic
syndrome [32]. Thyroid-treated animals appear to
excrete a water load more quickly and rapidly, and to
be more resistant to water intoxication [51]. The hypo-
thyroid rat is also capable of a more prompt water
diuresis than the euthyroid animal. In contrast, both
hypothyroidism and hyperthyroidism have been
found to result in a delayed water diuresis in man [52—
55]. Adrenal cortical insufficiency does not seem to be
responsible for delayed diuresis in primary myxedema
[54]; the role of vasopressin remains unclear. Several
clinical studies indicate that hyperthyroidism is fre-
quently associated in man with an impairment in
urinary concentrating capacity. Hypercalcemia has
been stressed by Wijdeveld and Jansen [54] as an
occasional cause for marked interference with urinary
concentration and for excessive water loss and dehydra-
tion in thyrotoxicosis. In most instances, the impair-
ment is much less severe and more difficult to charac-
terize.
In careful long-term balance studies of five women
with severe thyrotoxicosis, Weston et al [56] failed to
elicit antidiuretic responses with vasopressin com-
parable to those observed in cardiac patients or
normal subjects after much smaller doses. The defect
persisted in one patient who had been placed on a low
salt intake in order to reduce the osmolar excretion
and was not observed in a normal control placed on
high salt and nitrogen intake to increase solute excre-
tion to levels comparable with those of hyperthyroid-
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ism. In one patient followed after successful treatment,
the antidiuretic response returned to normal in the
euthyroid state. Epstein and Rivera [57] could not
confirm these results, however, in measurements of
maximal urinary concentration (Umax in mOsm/kg) in
13 thyrotoxic patients. Intramuscular injection of a
single dose (5 U) of vasopressin-in-oil was followed by
a normal rise in Umax (average: 818 mOsm/kg, range,
640 to 994, in comparison with an average of 905
mOsm/kg and a range of 680 to 1180 in ten healthy
medical students). The two studies are not really
comparable, however, because osmolality was deter-
mined in four successive urine samples collected over
1 hr in the studies of Epstein and Rivera, whereas
measurements were made in pooled 24-hr collections
of urine by Weston et al. Hence, it is possible that the
responses observed by Epstein and Rivera in the
hyperthyroid patients were abnormally transient and
not detectable by Weston and his associates.
This question has not been explored but other
workers have brought forward evidence of abnormali-
ties in both short-term and long-term responses. Thus,
according to Wijdeveld and Jansen [54], deprivation of
water and liquid food (not solid) for 36 hr resulted in
greater fluid loss and in a smaller rise in urinary
osmolality in four of five normocalcemic hyper-
thyroid patients than in normal control subjects with
similar osmolar excretion. A normal but not maximal
antidiuretic response to 700 ml of 2.5% NaCl in these
patients suggested an intact neurohypophyseal func-
tion operating upon a defective renal mechanism.
More precise determinations by Cutler, Glatte and
Dowling [34] accord with these findings and conclu-
sions. They found it impossible to obtain normal
values for Urnax(36 hr of dehydration plus 5 U of vaso-
pressin-in-oil) in nine hyperthyroid subjects and six
normal volunteers receiving T3, while solute-free
water reabsorption (T°H20) during an osmotic
diuresis produced by infusion of 10% mannitol was
usually within normal limits. They believed these
results are best explained by a fall in medullary
osmolality secondary to perfusional washout, possibly
in combination with diminished sodium reabsorption.
This inference is based on the observation of a rise in
glomerular filtration and renal plasma flow in normal
subjects which was not observed in the hyperthyroid
patients.
Evaluation of these effects in experimental animals
is clouded not only by the lack of sufficient data on
renal hemodynamics and glomerular filtration but
even more importantly by the need to use anesthesia
and by the problem of establishing comparable con-
trols. These problems are evident, for example, in a
study by Toretti, Marusié and Martinez [58], in
which urinary concentrating ability was evaluated in
rats given L-thyroxine, 800 g/ 100 g of body wt intra-
peritoneally daily for seven days, and fed low or high
sodium diets. All measurements were made during the
last 12 hr of a 24-hr period of water and food depriva-
tion. Urinary urea output proved to be significantly
higher (74.4% on the average) in the thyroid-treated
animals than in the controls, because both flow and
urea concentration were increased, presumably as a
result of augmented catabolism and neoglucogenesis
in the fasting state. It is impossible, however, to be
certain that differences in fecal refection (i.e., ingestion
of stool) after, and in dietary intake just prior to,
removal of food and fluid may not have made con-
tributions. In any case, the resulting difference in
osmolar excretion and in osmolar clearances invali-
dates the authors' conclusion that the statistically
significant differences in T°H20 (14.0 t.tl/min/lOO g—
hyperthyroid; 9.3 and 8.5 ii/min/l00 g—control) are
biologically significant. In addition to the need to
compare values for T°H20 at the same osmolar clear-
ance (Cosm), it is also necessary, as Buckalew, Ramirez
and Goldberg [59] have shown for the normal rat, and
Holmes and DiScala [60] for the hypothyroid, to
examine the expected linear relationship between
T°H20 and Cosm to levels as high as 150 to 250 .d/
min/lOO g. Under these circumstances of an osmotic
diuresis, it is also impossible to achieve maximal values
for Umax, and one would have expected the urinary
osmolality in the thyroid-treated rats, therefore, to
have been considerably less than, rather than equal to,
the control values as reported. This finding suggests,
indeed, as the authors point out, that "the concentra-
ting mechanism in these rats is more efficient than
that of the controls." This supposition is given some
support in an experiment (Table 1), in which osmolar
outputs (and presumably clearances) were brought to
approximate equality by intraperitoneal administra-
tion of isotonic urea solution (2.5 ml/l00 g) to normal,
T4-treated (100 g/100 g/day for 23 days), and hypo-
thyroid ('311-treated) rats (Réville and Stéphan, un-
published data). Urine was collected during 5-hr
periods in a metabolism cage without access to food or
water. As shown in Table 1 the urine osmolality was
significantly increased by hyperthyroidism and re-
duced by hypothyroidism in spite of similar outputs of
osmotically active solutes, urea and potassium. In a
second experiment [61], reduction in body protein
catabolism and in urea excretion by allowing free
access to dry food during a 24-hr period of water
deprivation resulted in (Table 2) a marked reduction in
osmolar excretion and permitted the normal control
rats to excrete a much more concentrated urine
(4275 mOsm/kg—Table 2, as compared with 2529 and
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Table 1. Urinary concentration and solute output after an intraperitoneal isotonic urea load (2.5 ml/100 g of body wt) to normal,
hypo- and hyperthyroid rats
N V, ml/5 hr/ Uosm, UV/5 hr/100 g of body wt
100 g of mOsm/kg
body wt H20 iOsm Urea Na, pEq K, jEq
mo1es
Normal rats (N) 18 J•39b 1,059 1,426 1,227 65.7 50.1
Thyroxine treated rats 18 1.18 1,418 1,594 1,314 54.2 88.5
100 ,g/100gof body wt/day/
23 days (T)
1311-treated rats (1) 18 2.91 528 1,520 1,273 133.8 84.8
N vs. T P NS <0.01 NS NS NS <0.01
N vs. I P <0.001 <0.001 NS NS <0.001 <0.01
I vs. T P <0.001 <0.001 NS NS <0.001 NS
V: urine flow; Uo,m: urinary osmolality; UV: urinary output.
b Mean SEM.
Table 2. Urinary concentration and solute output during 24 hr of water deprivation in normal and hyperthyroid rats
N V, ml/5 hi/ Uom, UV/5 hr/100 g of body wt
100g of mOsm/kg
body wt of H20 Osm Urea, Na, jEq K, ,Eq
moles
Normal rats (1) 6 0•14b 4,275 549 209 38 69
Thyroxine treated rats 6 0.37 3,690 1,343 420 57 176
100 g/100gof body wt/dav/
19 days (2)
Thyroxine treated rats 6 0.56 2,649 1,443 856 71 197
500g/100gofbodvwt/day/
14 days (3)
1 vs. 2 P <0.05 NS <0.01 <0.01 NS <0.01
I vs. 3 P <0.01 <0.001 <0.01 <0.01 <0.02 <0.001
2 vs. 3 P NS <0.01 NS <0.02 NS NS
V: urine flow; Uosm: urinary osmolality; UV: urinary output.b Mean±sEM.
2665 mOsm/kg in the controls of Toretti et al [58]).
Under these circumstances, rats which had received
T4 in doses of 100 g/100 g/day for 19 days were found
to concentrate the urine as well as the control animals
despite maintenance of a higher urea excretion (Table
2; all values are computed in terms of 5-hr periods,
from the total quantities collected in 24 hr in orderto
permit comparison with the figures in Table 1), in
agreement with Toretti's observations. With a more
striking hyperthyroidism following administration of
larger amounts of T4 (1000 g/day for 14 days), a less
marked increase in urinary osmolality occurred. The
concentrations of urea, ammonia, sodium and potas-
sium in the renal cortex, medulla and papilla of kidneys
from moderately hyperthyroid rats did not differ
significantly from normal according to Toretti.
Similar measurements of medullary concentration
gradients have not been made in more severely
thyrotoxic animals.
Osmoregulation in myxedema is equally obscure
and variably disturbed. As a rule the ability to dilute
and to concentrate the urine remains within normal
limits [62]. A delay in the excretion of water load has
been noted by several authors [52, 53] and shown to
vanish following substitution therapy. A thoughtful
review of this phenomenon by Papper and Lancestre-
mere [63] concludes with the opinion that it is probably
attributable in the main to the characteristic reduction
in glomerular filtration that clears with appropriate
treatment. Since adrenocortical insufficiency is associ-
ated with hypothyroidism secondary to panhypo-
pituitarism and may even be to some extent a by-
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product of primary hypothyroidism alone [64], it has
been difficult to dismiss it as the primary cause. Failure
to correct the deficit with cortical steroids in man,
however, together with conclusive evidence of entirely
normal cortical function in many instances, strongly
supports the view that thyroid deficiency alone is
responsible in some manner [52, 53, 65]. Water reten-
tion and hyponatremia have been so marked in occa-
sional instances that severe water intoxication with
coma has occurred [66—69]. The possibility that such a
syndrome might be caused by excessive and in-
appropriate vasopressin secretion has been given
serious consideration but as yet without persuasive
physiologic or biochemical backing. Demonstration
[70] that the accumulation of mucinous material in
myxedematous skin is acid mucopolysaceharide with a
preferential increase in hyaluronic acid has stimulated
speculation regarding the role of water "binding" in
the tissues as a cause for water retention, but here,
again, the limited information available fails to be
convincing. It seems much more likely that the essen-
tial lesion lies within the kidney.
In rats made hypothyroid by thyroidectomy or by
treatment with radioiodine or propylthiouracil, small
subcutaneous doses of vasopressin (10 and 20 mU)
were found [71] to evoke a normal antidiuresis with
urinary osmolar concentrations as high as those
observed in euthyroid controls. (With larger, longer-
acting doses of Pitressin-in-oil [250 mU], however,
Fregly [72] reported a response which was less than
normal, possibly because his animals had also under-
gone hypophysectomy.) It seems to be generally
agreed [73, 74] that an osmotic load, whether produced
by i.v. administration of 20% mannitol or 3% saline
solutions, fails to elicit normal reabsorption of solute-
free water or TcH2O. This defect in water conservation
is evident in the data portrayed in Fig. 5, where it can
be seen that hypothyroid rats differed on the average
from age-matched controls in presenting a lower body
weight and urinary osmolality and a greater urinary
output even during a period of hydropenia. Although
the medullary concentration gradient seems to be
within normal limits [75], hypothyroid rats lose
increasingly more water at higher levels of osmolar
excretion than euthyroid controls during water
deprivation (Fig. 6). The cause for this deficiency
appears to be in a tendency for the hypothyroid rat to
lose sodium under these conditions (Table 1) (indeed,
as will be seen, under all conditions) and in doing so to
maintain a quasi-osmotic diuresis. Insufficient data are
available to tell whether this is a general phenomenon
affecting all mammals to a varying degree or a
peculiarity of growing animals like the laboratory rat.
Sodium and potassium excretion. The regular and
Euthyroid rats ______________
Hypothyroid rats
(Treated with PTU)
Fig. 5. Mean daily body weight, urine volume and urine osmolality
in five female euthyroid and five female PTU-treated rats, during
free access to a 0.5% sodium chloride solution and during a 24 hr
period of fluid deprivation. Hypothyroid rats exhibited a higher
urinary output and a lower urinary osmolality during the period
of thirst than the controls.
characteristic changes in renal blood flow and
glomerular filtration rate that develop during thyroid
disease necessarily imply a disorder in body electrolyte
regulation by the kidney. Implicit in the hyperfiltration
of hyperthyroidism is a corresponding increase in
tubular reabsorption of sodium, and the hypofiltration
of hypothyroidism implies a decrement. Because of
the efficiency of compensating reactions and the usual
laggard chronic course that allows ample time for
them to develop, however, any residual disturbances
are minimal and subtle at most. it is entirely possible,
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Fig. 6. Urine flow as afunction of osmolar output in 18 euthyroid
and 20 hypothyroid rats during a 24 hr period of fluid deprivation.
The regression lines differ significantly, indicating that hypo-
thyroid rats needed a higher urine flow to excrete a given osmolar
load.
indeed, that the circulatory rearrangements them-
selves may be secondary rather than primary in
nature. Just as differing systemic circulatory patterns
probably reflect differences in tissue needs for oxygen
and other nutrients, so, too, may changes in renal per-
fusion and GFR indicate tubular ability to keep
electrolyte and water excretion within normal bounds.
Examined from this point of view, the hyperfiltration
of hyperthyroidism would be expected, on the one
hand, to necessitate augmented tubular reabsorptive
activity to prevent loss of water and salt or, on the
other, to be necessary to overcome an otherwise
dangerous excess in reabsorptive activity. And simi-
larly in hypothyroidism, the reduction in GFR may
require salt and water rejection by the tubules to
assure adequate output or it may serve to correct for a
tubular deficit. Much more work is needed to clarify
the full character of renal function at rest and under
various stresses in the course of the development of
thyroid over- or underactivity. Nevertheless, in the
light of the data discussed up to this point, a case
could be made for the hypothesis that defective tubular
transport of sodium is the "single action" that precipi-
tates a cascade of interacting reparative responses
within which the primary event is almost totally
obscured. Detrimental secondary events like heart
failure, arrhythmias, hyperthermia, arterial hypo-
tension or hypertension, impaired growth, tissue
destruction and satellite endocrinopathies all add to
the confusion.
The clinical evidence for this thesis is very far from
convincing. Sodium and water retention do not occur
in hyperthyroidism in the absence of heart failure.
Plasma sodium and potassium levels are normal.
Measurements of total body electrolytes are few and
conflicting. Whatever change there may be might well
be attributable simply to shifts and redistributions
consequent upon weight loss. Thus, Shizume and his
associates [76] found significantly increased values for
total exchangeable sodium in terms of body weight
and lean body mass in 16 patients with thyrotoxicosis
(including two males) as did Wayne [77] in 20, but
Munro [78] failed to detect any significant change
following treatment and return to normal in a total of
23 patients. A similar uncertainty obtains for total
exchangeable potassium [76—78], not because values
for the average reduction are not impressive (rising as
much as 47.5% after therapy in Staffurth's [79] series)
but because loss of muscle mass is difficult to allow for.
In contrast, total body potassium has been found [80]
to rise significantly above controls in dogs given T4
daily for three weeks. Exchangeable body sodium and
body water are variably elevated in patients with
hypothyroidism, particularly, of course, in the presence
of overt edema or cardiac failure. An equally variable
response to therapy has been reported [78, 8 1—84].
Here difficulty arises in connection with the possibility
of repartitioning extracellular water, possibly as a
result of the change in the character of interstitial
mucoprotein. Dorr and his associates [85] have found
that administration of a hypertonic sodium bicarbon-
ate solution increases extracellular water volume
(rapidly equilibrating sucrose space) in hypothyroid
animals. Infusion of 0.2 N HCI (25 mI/kg of body wt in
90 mm) was followed by a fall in interstitial fluid
volume of 5% in hypothyroid and a rise of 6°/' in
control animals [86].
Myxedematous patients have been found [37] to
excrete water and salt normally when given 10 g of salt
each day, whereas patients with rheumatic heart
disease and with equivalent values for renal blood
flow, GFR and cardiac output, failed to eliminate the
salt load and gained weight. Although this observation
would seem to speak for a relative tendency to salt
loss in myxedema, it may indicate simply a more facile
capacity for adjustment and homeostasis. In all these
investigations, well-established disease was present,
and information on the manner in which the final state
was reached is totally lacking. Repeated measure-
ments of body composition together with balance
studies must be made immediately after administra-
tion of thyroid hormones or thyroidectomy if the role
of the kidney is to be put into meaningful perspective.
Experimentally, too, it has not proved easy to
Water deprivation test
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define just how tubular sodium transport is affected.
Grant and his associates [87] have reported that
thyroid-treated animals conserve sodium and chloride
more efficiently than euthyroid controls and others
[88] have found that thyroid feeding tends to result in
chloride retention during high salt intake. Consistent
with these findings is the relative increase in the
capacity of the rat kidney to produce a concentrated
urine, at least with the lower doses of T4 noted above
(Tables 1 and 2). More precise measurements of the
effects of T3 and T4 on electrolyte reabsorption in
various portions of the nephron are needed. Much
more detailed studies of the hypothyroid rat have been
made because excess natriuresis is so prominent and so
easily produced by various manipulations. This
phenomenon was first discovered in 1959 by Stéphan,
Jahn and Metz [89] during the course of balance
studies of rats subjected to thyroidectomy or treated
with propyithiouracil for several months in sufficient
quantity to halt growth. Intraperitoneal injections of
5 ml of distilled water produced a marked diuresis in
both control and hypothyroid animals that had been
maintained on a salt-poor regimen. The hypothyroid
rats excreted up to 100.5 Eq of sodium in 5 hr in
contrast to the euthyroid controls that put out 9.8 and
10.3 Eq in the same period. Potassium excretion was
similarly but much less severely affected, up to 125
Eq in 5 hr, compared with 64.4 and 70.1 Eq in con-
trols. Treatment with thyroxine or termination of
PTU treatment resulted in restoration of normal
functional responses. With dehydration, too, salt loss
occurred (Table 1) and removal of salt from the diet
resulted in rapid deterioration and death. Intraperi-
toneal administration of isotonic solutions of sodium
chloride, potassium chloride and urea resulted in much
greater output of water and sodium by hypothyroid
rats (Fig. 7, closed circles) than by euthyroid controls
(Fig. 7, crosses) [90]. Roche, Michel and Jouan [91]
brought forward additional evidence for a negative
sodium balance in young hypothyroid rats and noted
the development of hyponatremia suggesting the
possibility of an underlying defect of adrenocortical
function.
Since atrophy of the adrenal cortex is regularly
present in hypothyroidism, hypoadrenocorticism may
well intensify or account entirely for the salt loss.
Combination of thyroidectomy and adrenalectomy
was found by Stéphan, Jahn and Metz [92] to cause a
much more marked loss of water and salt than did
either operation alone. Even with provision of salt and
water in sufficient amount to maintain the adrenalec-
tomized rats in good health, animals that had also been
thyroidectomized failed rapidly and died. In other
experiments, administration of desoxycorticosterone
acetate in doses which assured survival of euthyroid
adrenalectomized rats failed to prevent death of rats
+ Euthyroid
• Hypothyroid
Fig. 7. Relationship of urine flow to urinary sodium
output in euthyroid and hypothyroid rats following 5 ml
intraperitoneal injections of isotonic NaCI or urea. In each
instance, hypothyroid rats excreted more sodium and
proportionately more water than euthyroid controls [90].
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with the combined deficits. Similar findings have been
reported by Demanet [93] and by Fregly, Brimhall and
Galindo [94]. The latter had noted earlier that these
animals also evince an increase in spontaneous appetite
for salt and excrete urine with a higher Na/K ratio as
evidence for adrenal insufficiency. In addition, dietary
administration of PTU to rats for 20 weeks proved
[95] to reduce the rate of aldosterone secretion (i.e.,
from 3.4 to 2.5 ng/min/adrenal/100 g of body wt,
P< 0.01) 26% below that of euthyroid controls. In
unpublished experiments by Stephan and his associ-
ates, 24-hr water deprivation has been observed to
lower the Na/K ratio to normal values over a wide
range of sodium excretion in adrenalectomized rats
but not in hypothyroid animals. Treatment with
"physiological" doses of thyroxine (10 tg/l00 g of
body wt/day) quickly restores Na/K ratio, sodium
output and responses to solute loads and water
deprivation to normal in the hypothyroid rat. When
one considers the discrete nephron determinants of
sodium excretion, also, the evidence points clearly to
some intrinsic defect in tubular function that differs in
magnitude and character from that produced by lack
of adrenal-cortical hormones. Thus, according to
Holmes and DiScala [60], glomerular filtration
(inulin clearance), though reduced to 63% of control
on the average, remained unchanged while sodium
clearance increased to levels as high as 45% of the
filtered load in hypothyroid rats during administra-
tion of 5% sodium chloride solution. A maximal
increment of 9% has been observed under similar
conditions in completely adrenalectomized rats.
Fractional sodium excretion exceeded control by
330% in hypothyroid animals, in striking contrast to
an increment of only 1 to 2% after adrenalectomy.
Furthermore, direct measurement has failed to dis-
close any abnormality of the sodium concentration
gradient in the renal papilla of the hypothyroid rat,
whereas it is significantly reduced after adrenalectomy.
Certainly, the absence of any significant response to
therapy with large doses of hydrocortisone and aldo-
sterone most persuasively supports the conclusion that
adrenocortical deficiency must exert at most a minor
influence; but further work is needed to define how,
when and to what extent it may contribute not only in
experimental hypothyroidism but also in the disease in
man.
The important and careful micropuncture studies by
Michael, Barenberg, Chavez, Vaamonde and Papper
[96] have provided direct quantitative evidence of
diminished fractional fluid reabsorption in the proxi-
mal tubule—20% lower in hypothyroid than in con-
trol rats (P<0.001). Of considerable interest is their
further observation that proximal transit times of
Lissamine green did not differ significantly in the con-
trol and hypothyroid groups, because it implies slower
movement of filtrate down the shorter than normal
proximal convolution, presumably as a result of the
fall in SNGFR. From these data as well as those out-
lined above on glucose titration, it follows that
glomerulotubular balance is maintained and that the
resultant retardation in the rate of filtrate perfusion is
nevertheless insufficient to keep reabsorption within
normal limits. Whether this phenomenon is simply the
result of diminished tubular mass, the imposition of
impulses to sodium rejection from the body mass that
continues to grow, a more discrete effect of impaired
development (or atrophy?) or some other cause, it is
evident that a larger than normal load of residual
filtrate enters the equally stunted more distal segments
for processing. Even in the absence of an intrinsic
defect in distal tubular function, this intersegmental
loading imbalance would be expected to predispose to
exaggerated natriuresis. The fact that sodium output
amounts to three times the output in control rats
under the same conditions may bespeak a more distal
lesion as well.
The role of alterations in aerobic and glycolytic
metabolism and in renal sodium-potassium-activated
ATPase in the pathogenesis of these changes remains
most uncertain. Measurements of oxygen consump-
tion by the hypothyroid kidney in rats have not been
made in vivo during varied sodium loads. A decrement
in cortical Q02 without significant change in anerobic
glycolysis during hypothyroidism has been inter-
preted [97] as evidence that the "natriuretic response
of the hypothyroid rat is a consequence of an insuffi-
cient supply of energy for active sodium transport."
The changes observed in Q02 of renal tissue slices are
of uncertain relevance to reabsorptive activity, how-
ever, since they relate to tissue no longer engaged in
urine formation or capable of coordinated filtrate
processing. The ingenious experiments devised by
Katz and Lindheimer [15] to show that the deficiency
in renal Na-K-ATPase in the hypothyroid rat may be
an adaptive response to decreased reabsorptive sodium
load rather than an effect of the hormone deficiency
per se indicate persuasively that Na-K-ATPase and
sodium reabsorption are closely correlated. It would
be interesting to know if renal oxygen consumption
per unit mass also rises in vivo and in vitro during
compensatory hypertrophy and methylprednisolone
treatment. More data are needed on the sequence of
changes in sodium loading and oxygen cost of sodium
transport, in growth retardation, in diminution in
oxygen uptake and Na-K-ATPase and in tubular
sodium rejection following thyroidectomy. At present
it can only be said that tubular dysfunction occurs in
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hypothyroidism; but whether it is basically dimen-
sional, organizational, neurohumoral, or biochemical
in origin remains unknown.
Calcium, phosphorus and acid-base balance. Hyper-
calcemia occurs not infrequently in the course of
hyperthyroidism. As a rule it is moderate in degree and
produces little, if any, secondary renal pathology or
dysfunction, Occasionally, however, serious damage
may be produced. Parfitt and Dent [98], for example,
have collected from the literature 18 cases including
two of their own in which prolonged hypercalcemia
(11.8 to 19.2 mg/l00 ml) was associated with azotemia,
anemia, hypercalciuria and hyposthenuria. Nephrocal-
cinosis has been reported in at least two instances [99,
100], but major pathology of this kind is rare and in
most instances hypercalcemia is moderate and
transient without much evidence of a renal effect
other than an impairment in concentrating ability
[101, 102]. Just how hypercalcemia acts to reduce
Umax and T°H20 is unknown. According to Epstein
[103] calcium and sodium appear to be handled by
similar, if not identical, transport mechanisms in the
proximal convoluted tubule that are affected in the
same way by extracellular fluid expansion or depletion.
In the more distal tubule, however, the two processes
appear to be disassociated, so that a marked reduction
in calciuria may occur in the face of a continuous
sodium loss, as during chronic administration of
diuretics, for example. With a rise in serum calcium
concentration, the sodium content of the medulla falls
and the calcium content increases. Normally the
tissue calcium concentration rises from cortex to
papilla [104], and it is therefore not surprising that
when calcium deposition occurs it produces pro-
gressively increasing damage from the thick ascending
limb to the terminal collecting system. To what extent
direct tubular action of thyroid hormones modifies the
action of hypercalcemia has not been evaluated.
None of the various theories to account for the
elevated serum calcium has proved very satisfactory
[98]. It is entirely possible that accelerated bone turn-
over, potentiation of parathormone action, calcitonin
deficiency and potentiation of vitamin D activity may
each play a part at different times in some varied
combination and degree. Simultaneous overactivity of
the parathyroids has proved particularly difficult to
rule out. Thyrotoxicosis occurs ten times more often
among patients with primary hyperparathyroidism
than in the population at large, so that an association
of the two conditions is not improbable. It might be
supposed, furthermore, that the parathyroid glands
could be stimulated in some instances by the local
hyperemia and increased tissue metabolism of hyper-
thyroidism. Other than the hypercalcemia itself, how-
ever, evidence for parathyroid hyperactivity is usually
lacking. When demonstrable primary disease is
present, in fact, hypercalcemia does not respond to
correction of the thyroid disorder alone but requires
removal of the parathyroid adenoma. Antithyroid
medication alone, on the other hand, is sufficient to
restore calcium levels to normal in hyperthyroidism.
Moreover. urolithiasis is a common feature of hyper-
parathyroidism, but it occurs in hyperthyroidism with
no greater frequency than in the general hospital
population [105]. Finally, the high plasma phosphate
level, the high calcium clearance and a normal value
for parathormone level in one instance [106] are
opposed to active parathyroid participation. The
development of a better understanding and better
quantitative analysis of parathyroid function should
soon settle this question. The recent demonstration
[107] of the importance of the kidney in producing the
final highly active metabolite of vitamin D3—i.e.,
1,25-dihydroxycholecalciferol—is also of special rele-
vance in this connection. Enhanced 1-hydroxylation in
the hyperthyroid kidney could well play a critical role
in stimulating gastrointestinal absorption of calcium,
in the mobilization of bone calcium, and perhaps also
in modifying tubular reabsorption of calcium and
phosphate.
Maximal tubular reabsorption of phosphate appears
to be increased in the dog following administration of
T3 and in patients with severe thyrotoxicosis [108].
This finding is consistent with the increase in glucose
Tm and is not actually at odds with the usual hyper-
phosphaturia [109]. Plasma phosphate levels do not
usually reach values sufficient to exceed the tubular
saturation limit, so that the "splay" normally evident
in the relationship between filtered load and reabsorp-
tion at levels below Tm may well be sufficient to permit
substantial urinary loss [110]. Splay could be increased,
too, (as it is in metabolic acidosis) either as a result of
direct action of T3 and T4 or as a concomitant of the
heightened metabolic activity. Although hypercalciuria
and hyperphosphaturia point to an augmented bone
catabolism, which is evident at times in overt osteo-
porosis, it is also symptomatic of the general catabolic
state. The tendency to acidosis under these circum-
stances is rarely evident, presumably because acid
excretion is well-maintained. Thus, Zisman et al [ill]
have reported that acidification of the urine, ammonia
output and urinary titratable acidity were all increased
normally two hours after oral administration of an
ammonium chloride load (2 mEq/kg) to five patients
with untreated hyperthyroidism and with serum
calcium levels at or just above the upper limit of
normal. In 1959, Huth, Mayock and Kerr [99] de-
scribed a patient with persistent renal tubular acidosis
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(RTA) in association with nephrocalcinosis that came
on abruptly during an episode of hyperthyroidism at
the age of 44 without any preceding illness, familial
disorder or other obvious cause. In a second case
reported in 1968 by Zisman and his associates [111],
discovery of nephrocalcinosis and RTA preceded the
appearance of demonstrable hyperthyroidism by two
years and did not clear with successful management of
the thyroid disease. Hypergammaglobulinemia was
noted and attention called to the frequency with which
this abnormality is associated with RTA [112]. A more
recent paper by Mason and Golding [113] stresses this
aspect in the description of three patients, in all of
whom RTA developed in the course of "autoimmune
thyroid disease" accompanied by hypergamma-
globulinemia. In one, RTA was discovered 13 yr
after onset of thyrotoxicosis treated by removal of a
gland showing the changes of Hashimoto's thyroiditis
and after a slowly progressive course marked by the
onset of keratoconjunctivitis sicca, purpura, rheuma-
toid arthritis and fibrosing alveolitis. Primary biliary
cirrhosis, keratoconjunctivitis sicca, fibrosing alveo-
litis and overt RTA appeared in a second patient nine
months after the onset of thyrotoxicosis that had
responded to antithyroid therapy. In contrast, spon-
taneous myxedema and "sicca complex" occurred
three years before the onset of systemic acidosis due to
RTA in the third patient. Study of renal acidification in
eight patients with myxedema by these authors showed
a normal response to an ammonium chloride load in
all but one whose euthyroid identical twin sister was
then also discovered to respond abnormally to the acid
load and to show, like all the others with RTA,
abnormalities of immunoglobulins. On these findings
it seems reasonable to conclude that RTA is not
specifically related to thyroid hormone excess or
deficit but is caused by a complicating disorder that
may also affect the thyroid.
Hypercalcemia occurs rarely in myxedema under
even more puzzling circumstances than those under
which it appears in hyperthyroidism. This manifesta-
tion has been observed [114—116] rarely among
children and reported [117] at least once in an adult
with myxedema. Both adults and children with idio-
pathic hypothyroidism tend to put out less calcium in
stools and urine than normal subjects on the same diet
[118, 119] and the rate of disappearance from the
blood following intravenous administration of 45Ca is
decreased [120]. In keeping with this is the additional
finding of a greater and more prolonged increase in
serum calcium in 8 of 11 patients with hypothyroidism
than in normal controls following ingestion of 40°/
calcium chloride solution. In one normocalcemic
myxedematous patient, the calcium load resulted in
marked hypercalcemia (16 mg/lOO ml) which persisted
for three days before return to the normal level.
Experimental study of the hypothyroid rat has yielded
data indicating considerably less absorption from the
gut (46% of a dose of calcium chloride remaining in
the gut as compared with 28% in the control), less
deposition in bone (serum-bone specific activity ratio
of 560 vs. 370) and higher serum levels (12.3 to 16.8 vs.
10.8 to 15.7 mg/lOO ml) two hours after giving calcium
chloride (20 mg/100 g of body wt labelled with 20 Ci
of 45Ca) by gastric intubation. If these results may be
extrapolated to the long-term situation and to man, it is
possible that an impairment in intestinal absorption
of calcium acts to prevent hypercalcemia in the adult
on the usual diet but is perhaps less effectively protec-
tive in the child receiving an abundance of calcium in
milk. The character of calcium excretion in the urine
under these circumstances deserves more precise
characterization particularly in relation to phosphate
and hydrogen ion output.
Concluding comment
The kidney evinces a remarkable capacity to adjust
to the deformities and dysfunctions that may result
from thyroid disease, apparently continuing to per-
form its homeostatic role by maintaining body fluid
composition and volumes within reasonably normal
limits under normal circumstances. The circulatory
adjustments that have been discussed above might be
expected, however, to compromise renal vascular
responses in such cardiovascular disturbances as
heart failure and hemorrhagic shock, while the tubular
disorders might well affect the kidney's ability to deal
appropriately with changes in load. Certainly, the
greatly augmented dietary intake and catabolic load in
hyperthyroidism seems to be handled without great
difficulty in most instances, in the absence of cardiac
incompetence. It is possible, nevertheless, that con-
gestive heart failure in both thyrotoxicosis and
myxedema may actually stem in part from a failure of
renal compensations, and that circulatory collapse
may arise or at least occur more readily in both as a
result of altered renal tubular, vascular and humoral
responses. The excessive loss of sodium by the hypo-
thyroid rat, for example, clearly predisposes to, or
causes, shock. Whether a similar failure may occur
in man or other animals remains undetermined. To
what extent the renin-angiotensin system may be
adversely affected is also unknown. In this connection
it may be noted that hypothyroidism appears to slow
the development and diminish the severity of experi-
mental renal hypertension, whereas thyroid hormone
exerts the reverse effect [121, 122]. With the rise in
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arterial pressure following renal encapsulation or
during administration of deoxycorticosterone acetate
in the rat, the weight of the thyroid gland increases
while thyroidal 1311 uptake falls, according to Field,
Fregly and Kim [123]. They ascribe this phenomenon
to release of a renal medullary "thyroid-depressing
factor" which has not yet been characterized. Evalua-
tion of renal homeostatic interaction and adjustments
is particularly difficult in thyroid diseases because of
the presence of extrarenal disturbances that are usually
assigned a primary role with the kidney regarded, as it
is throughout this review, as victim rather than culprit.
The application of modern techniques to a systematic,
quantitative reappraisal of renal physiology and mor-
phology under carefully controlled conditions of
thyroid hormone excess or deficit is needed to help put
these questions in a true perspective.
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